Le Lézard
Classified in: Health, Covid-19 virus
Subject: FDA

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients


ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherapy techniques. Harmony perfectly balances productivity and precision without compromise, making the system well-suited to address changing U.S. demographics and practice patterns.

"The cancer burden in the United States and worldwide is increasing significantly, arising not just from an aging population, but also from delayed diagnoses and treatments due to Covid-19," notes Larry Biscotti, Elekta's Executive Vice President Region North & Central America. "Harmony was designed not only to enable the latest advanced radiotherapy techniques, but also to simplify and streamline the radiotherapy process, with guided workflows and a user interface that facilitates a short learning curve. The interface gives the treatment staff all the information they need where they need it. The results are shorter treatment times, greater productivity and more patients treated."

"Research results are pointing to the clinical value of hypofractionation for a variety of malignancies, including prostate, breast, and lung cancers," adds John Christodouleas, MD, MPH, SVP of Medical Affairs & Clinical Research Linac-Based RT. "The trends in patterns of care data suggest that hypofractionation ? enabled through systems capable of stereotactic body radiotherapy [SBRT] ? is going to be routine at all radiotherapy centers," he says. "If only 10 percent of metastatic carcinoma patients are treated with SBRT once or twice throughout their treatment course, SBRT will be in considerable demand. When we designed Harmony, SBRT indications were a priority."

A versatile system that can operate effectively in highly distributed, suburb-based radiotherapy clinics that are part of a larger network is also valuable, Christodouleas says.

"In cancer care, we're seeing a shift in which networks are siting many machines to cover large geographic areas to bring treatment closer to where people live," he observes. "These networks need delivery systems that can handle both technically demanding treatments like SBRT and also more conventional IGRT regimens. Harmony was built as an efficient, versatile linear accelerator allowing clinicians to treat more patients with high-quality precision radiation therapy."

Harmony will provide enhanced:

To register for the launch event, visit: https://findyourbalance.elekta.com/us/.

*Elekta Harmony has CE mark and U.S. FDA 510(k) clearance. Not available in all markets.

**Data maintained internally

For further information, please contact:

Mattias Thorsson, Vice President, Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  

Time zone: CET: Central European Time

Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, e-mail: Raven.Canzeri@elekta.com

Time zone: ET: Eastern Time

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to ? and benefits from ? more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-radiotherapy-system-designed-for-changing-cancer-landscape-now-available-for-u-s--patients,c3368721

The following files are available for download:

https://mb.cision.com/Main/35/3368721/1433026.pdf

Harmony 510k_PR_final

https://news.cision.com/elekta/i/harmony-hires-8alt-approved,c2926149

Harmony hires 8alt approved

https://news.cision.com/elekta/i/harmony-hires-0-approved,c2926150

Harmony hires 0 approved

https://news.cision.com/elekta/i/harmony-hires-2-approved,c2926151

Harmony hires 2 approved

 

SOURCE Elekta


These press releases may also interest you

at 09:46
In the news release, NFL Alumni Performance Labs Forms Exclusive Partnership with to Deliver Best-in-Class Predictive Vital Sign Analytics, issued 20-Oct-2021 by Nervotec over PR Newswire, the release headline should read "NFL Alumni Performance Labs...

at 09:38
Skroot Laboratory, Inc. has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium of universities, companies, and clinical collaborators brought together to develop...

at 09:37
Encompass Health Corporation today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.28 per share, payable on Jan.18, 2022, to holders of record on Jan. 3, 2022....

at 09:30
The "Global DNA Microarray Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The DNA microarray market is poised to grow by $2.61 bn during 2021-2025, progressing at a CAGR of 12.00%. The market is driven by advances in...

at 09:30
The global culture media market size was USD 5.43 billion in 2020 and is expected to register a CAGR of 9.3% between 2021 and 2028. Steady market revenue growth is driven by rising need for monoclonal antibodies, growing emphasis on personalized...

at 09:25
Petros Pharmaceuticals, Inc. , a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will participate in the following Benzinga events: Benzinga All Access Show Mr. Boctor will...



News published on 17 june 2021 at 02:24 and distributed by: